Amicus Therapeutics - FOLD Short Interest Ratio & Short Volume

Short interest is the volume of Amicus Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 28th, traders have sold 18,090,000 shares of FOLD short. Learn More on Amicus Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FOLD shares currently have a short interest ratio of 9.0. Learn More on Amicus Therapeutics's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Amicus Therapeutics: Jane Street Group LLC, SG3 Management LLC, Susquehanna International Group LLP, Group One Trading L.P., Cowen AND Company LLC, Citigroup Inc., Simplex Trading LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Amicus Therapeutics saw a increase in short interest during the month of February. As of February 28th, there was short interest totaling 18,090,000 shares, an increase of 0.2% from the previous total of 18,060,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "biotechnology" compare to Amicus Therapeutics: Madrigal Pharmaceuticals, Inc. (7.43%), Alkermes plc (5.46%), Ironwood Pharmaceuticals, Inc. (10.72%), Dynavax Technologies Co. (12.66%), Ligand Pharmaceuticals Incorporated (5.23%), MannKind Co. (13.22%), OPKO Health, Inc. (9.01%), Geron Co. (6.45%), ImmunoGen, Inc. (10.09%), and United Therapeutics Co. (2.87%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Suncor Energy Inc. ($3.27 billion), Occidental Petroleum Co. ($2.77 billion), Coinbase Global, Inc. ($2.25 billion), T. Rowe Price Group, Inc. ($2.23 billion), Paramount Global ($1.92 billion), Etsy, Inc. ($1.75 billion), Voya Financial, Inc. ($1.74 billion), CarMax, Inc. ($1.62 billion), Old Dominion Freight Line, Inc. ($1.62 billion), and Royal Caribbean Cruises Ltd. ($1.39 billion). View all of the most shorted stocks.

Short selling FOLD is an investing strategy that aims to generate trading profit from Amicus Therapeutics as its price is falling. FOLD shares are trading up $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Amicus Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FOLD, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FOLD, twice per month. The most recent reporting period available is February, 28 2023.